These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7165325)

  • 1. Determination of 8-methoxypsoralen levels in plasma and skin suction blister fluid by a new sensitive fluorodensitometric method.
    Korting HC; Schäfer-Korting M; Roser-Maass E; Mutschler E
    Arch Dermatol Res; 1982; 272(1-2):9-20. PubMed ID: 7165325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenced of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients.
    Herfst MJ; De Wolff FA
    Eur J Clin Pharmacol; 1982; 23(1):75-80. PubMed ID: 7128674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of citropten and bergapten in suction blister fluid after solar product application in humans.
    Makki S; Treffel P; Humbert P; Agache P
    J Chromatogr; 1991 Feb; 563(2):407-13. PubMed ID: 2056004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of 8-methoxypsoralen in suction-blister fluid and serum by liquid chromatography.
    Herfst MJ; Edelbroek PM; de Wolff FA
    Clin Chem; 1980 Dec; 26(13):1825-8. PubMed ID: 7438426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peak blistering point: influence on fluid levels of 5-MOP in human skin in vivo after systemic administration.
    Humbert P; Treffel P; Makki S; Millet J; Agache P
    Arch Dermatol Res; 1991; 283(5):297-9. PubMed ID: 1929553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of methoxsalen in human serum, suction blister fluid and epidermis by gas chromatography mass spectrometry.
    Huuskonen H; Koulu L; Wilén G
    Photodermatol; 1984 Jun; 1(3):137-40. PubMed ID: 6527955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid.
    Lauharanta J; Juvakoski T; Kanerva L; Lassus A
    Arch Dermatol Res; 1982; 273(1-2):111-4. PubMed ID: 7184466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citropten and bergapten suction blister fluid concentrations after solar product application in man.
    Treffel P; Makki S; Faivre B; Humbert P; Blanc D; Agache P
    Skin Pharmacol; 1991; 4(2):100-8. PubMed ID: 1878243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of 8-MOP in serum and in suction blister fluid.
    Reymond JL; Beani JC; Racinet H; Bonnot D; Beriel H; Amblard P
    Photodermatol; 1988 Feb; 5(1):51-2. PubMed ID: 3353318
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum levels of 8-methoxypsoralen in psoriasis patients using a new fluorodensitometric method.
    Herfst MJ; Koot-Gronsveld EA; de Wolff FA
    Arch Dermatol Res; 1978 Jun; 262(1):1-6. PubMed ID: 686816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraindividual variations of 8-methoxypsoralen plasma levels.
    Schäfer-Korting M; Korting HC
    Arch Dermatol Res; 1982; 272(1-2):1-7. PubMed ID: 7165313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Goeckerman therapy on interferon in serum and suction blister fluid from patients with psoriasis.
    Livden JK; Bjerke JR; Degre M; Matre R
    Br J Dermatol; 1986 Feb; 114(2):217-25. PubMed ID: 2418865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoralen-ultraviolet A-induced erythema: sensitivity correlates with the concentrations of psoralen in suction blister fluid.
    Yeo UC; Shin JH; Yang JM; Park KB; Kim MM; Bok HS; Lee ES
    Br J Dermatol; 2000 Apr; 142(4):733-9. PubMed ID: 10792224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photobiological activity of suction blister fluid from patients treated with 8-methoxypsoralen.
    Dubertret L; Averbeck D; Prognon P; Blais J; Vigny P
    Br J Dermatol; 1983 Oct; 109(4):421-7. PubMed ID: 6354243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of hyaluronate in suction blister fluid from active psoriatic lesions.
    Lundin A; Engström-Laurent A; Michaëlsson G; Tengblad A
    Br J Dermatol; 1987 Mar; 116(3):335-40. PubMed ID: 3567072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A levels in suction-blister fluid of patients with psoriasis treated systemically.
    Meinardi MM; Van Eendenburg JP; Oosting J; Van Boxtel CJ; De Rie MA; Bos JD
    Br J Dermatol; 1990 May; 122(5):671-6. PubMed ID: 2354118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
    Lauharanta J; Paravicini U
    Arch Dermatol Res; 1982; 272(1-2):147-9. PubMed ID: 6219628
    [No Abstract]   [Full Text] [Related]  

  • 18. Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(1):109-13. PubMed ID: 4054199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of phototoxic and photogenotoxic risk associated with the use of photosensitizers in suntan preparations: application to tanning preparations containing bergamot oil.
    Moysan A; Morlière P; Averbeck D; Dubertret L
    Skin Pharmacol; 1993; 6(4):282-91. PubMed ID: 8198814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.